The majority of patients with cystic fibrosis (CF) will grow into adulthood. Despite this improvement in survival, the disease is progressive, especially with respect to the decline in pulmonary function, which in turn may have an impact on a patient's quality of life. In this study we evaluated the
Treatment of anorexia and weight loss with megestrol acetate in patients with cystic fibrosis
โ Scribed by Samya Z. Nasr; Martin E. Hurwitz; Randall W. Brown; Mahmoud Elghoroury; David Rosen
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 22 KB
- Volume
- 28
- Category
- Article
- ISSN
- 8755-6863
No coin nor oath required. For personal study only.
โฆ Synopsis
Four patients with severe cystic fibrosis lung disease, anorexia and weight loss, received Megestrol Acetate (MA), as an appetite stimulant. The initial dose was 400-800 mg daily and was continued for 6-15 months. Appetite was improved, with significant weight gain in all patients and an increase in their weight for age percentile from <5% at the start of the study to approximately the 25 th percentile after 6 months of use and improvement in quality of life. One patient discontinued MA after 6 months, and subsequently appetite and weight were depressed.
๐ SIMILAR VOLUMES
## Objective: The purpose of this study was to investigate the relationship between premorbid weight and weight upon referral for inpatient treatment in patients with anorexia nervosa (an). ## Method: Forty-nine consecutively ascertained female inpatients with an were asked to recall their premor
Plasma testosterone was measured in three males and thirty-six female patients before and after treatment for anorexia nervosa. Low testosterone values were found before treatment, and weight gain was associated with an increase to normal levels. LH, and to a lesser extent FSH, increased during trea
Males with cystic fibrosis (CF) are generally infertile as a result of aberrant development of Wolffian duct derivitives. The personal significance of this and related reproductive and sexual health (RSH) issues is unknown. We set out to describe the knowledge, attitudes, and experiences regarding R